Gerlach, Tilman

Publishing since 2000 (Junior)

Has published 13 publications in 11 years

Number of publications published per year by Gerlach, Tilman. (Source : PubMed)

Distribution of publications types for Gerlach, Tilman. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Bruggmann P, Dampz M, Gerlach T, Kravecz L, Falcato L. Treatment outcome in relation to alcohol consumption during hepatitis C therapy: An analysis of the Swiss Hepatitis C Cohort Study. Drug Alcohol Depend 2010
Dintsios CM, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns MP, Krauth C. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany. Eur J Gastroenterol Hepatol 2010;22;3
Sgier C, Müllhaupt B, Gerlach T, Moradpour D, Negro F, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF. Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. J. Viral Hepat. 2010
Berg T, Weich V, Teuber G, Klinker H, Möller B, Rasenack J, Hinrichsen H, Gerlach T, Spengler U, Buggisch P, Balk H, Zankel M, Neumann K, Sarrazin C, Zeuzem S. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Hepatology 2009;50;2
Johansen P, Storni T, Rettig L, Qiu Z, Der-Sarkissian A, Smith KA, Manolova V, Lang KS, Senti G, Müllhaupt B, Gerlach T, Speck RF, Bot A, Kündig TM. Antigen kinetics determines immune reactivity. Proc. Natl. Acad. Sci. U.S.A. 2008;105;13
Morsczeck C, Reichert TE, Völlner F, Gerlach T, Driemel O. [The state of the art in human dental stem cell research] Mund Kiefer Gesichtschir 2007;11;5
Kronenberger B, Berg T, Herrmann E, Hinrichsen H, Gerlach T, Buggisch P, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. Eur J Gastroenterol Hepatol 2007;19;8
Goetze O, Selzner N, Fruehauf H, Fried M, Gerlach T, Mullhaupt B. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry. Aliment. Pharmacol. Ther. 2007;26;2
Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 2006;130;4
Berg T, Sarrazin C, Hinrichsen H, Buggisch P, Gerlach T, Zachoval R, Zeuzem S. Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Hepatology 2004;39;5

[ See timeline ] [ See all publications ]

h=17

means that Gerlach, Tilman has 17 papers cited a least 17 times - methodology

Key figures

13 pub in 11 years
1.2 publications/year
best year 2010 with 3 pub
h-index 17 with 13 pub
h-ratio : 130 %

See Timeline

Ranking

It's me !

Click here if you are
Gerlach, Tilman.

Most frequent Journals

Hepatology (4x)
Eur J Gastroenterol Hepatol (2x)
Drug Alcohol Depend (1x)
Aliment. Pharmacol. Ther. (1x)
Vaccine (1x)

Main affiliation

Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitätsklinikum Charité, Campus Virchow-Klinikum, Humboldt-Universität, Berlin, Germany.

Latest co-workers

Berg T Buggisch P Diepolder H Goeser T Herrmann E Hinrichsen H Hopf U Jung MC Klinker H Kronenberger B Manns MP Müllhaupt B Nasser S Pape GR Rasenack J Sarrazin C Spengler U Wursthorn K Zachoval R Zeuzem S

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.